Akoya Biosciences Q1 2024 Adj EPS $(0.39) Misses $(0.29) Estimate, Sales $18.350M Miss $24.281M Estimate
Akoya Biosciences Q1 2024 Adj EPS $(0.39) Misses $(0.29) Estimate, Sales $18.350M Miss $24.281M Estimate
Akoya Biosciences2024年第一季度調整後每股收益美元（0.39）未達到預期（0.29）美元，銷售額爲1835萬美元，低於2428.1萬美元的預期
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.29) by 34.48 percent. The company reported quarterly sales of $18.350 million which missed the analyst consensus estimate of $24.281 million by 24.43 percent. This is a 14.29 percent decrease over sales of $21.410 million the same period last year.
Akoya Biosciences（納斯達克股票代碼：AKYA）公佈的季度虧損爲每股0.39美元，比分析師普遍預期的0.29美元（0.29美元）低34.48％。該公司公佈的季度銷售額爲183.5億美元，比分析師普遍預期的2428.1萬美元低24.43％。這比去年同期的2141.0萬美元的銷售額下降了14.29％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。